| 10 June 2026 |
revision 2026.032 |
|
| 9 June 2026 |
Upcoming change to serum free light chains reference ranges. |
revision 2026.031 |
| 3rd June 2026 |
New email address for complaints, see Contact us. |
revision 2026.030 |
|
Update to urine cystine turnaround time. |
revision 2026.029 |
|
| 27 May 2026 |
Updated turnaround times at referral laboratory for ganglioside GM1 antibody, ganglioside GQ1b antibody, haptoglobin and lacosamide. |
revision 2026.028 |
| 20 May 2026 |
Due to a change of provider at our referral laboratory the methods for aldosterone and renin will change from 13 July 2026. Reference ranges will change and units for renin will change from mass units (mU/L) to renin activity measured in nmol/L/h. Results will not be comparable with previous. |
revision 2026.027 |
|
Upcoming reference range change for urine cortisol due to change of provider at referral laboratory. |
revision 2026.026 |
|
| 5 May 2026 |
Additional information added to D-dimer page. Time limit for analysing thrombophilia screen samples changed to 4 hrs. |
revision 2026.025 |
|
Addition to Microbiology specimens and requests page: Microbiology has recently validated an additional analyser for microorganism identification. Currently this analyser is not within the scope of our UKAS accreditation. This is notification that some microorganisms may have been identified using a non-UKAS 15189:2022 accredited analyser. |
revision 2026.024 |
|
|
Clarification for monitoring and finasteride added to thresholds for PSA. |
revision 2026.023 |
|
|
New method and reference ranges for urine creatinine. |
revision 2026.022 |
|
| 13 April 2026 |
Addition of faeces collection instruction to faeces microbiology. |
revision 2026.021 |
|
Virology updates including monthly performance data and updated contacts page. |
revision 2026.020 |
|
| 24 March 2026 |
Microbiology & Infection accreditation has been reinstated. |
revision 2026.019 |
| 11 March 2026 |
revision 2026.018 |
|
| 4 March 2026 |
Updates to histopathology referrals information and updated test list. |
revision 2026.017 |
| 25 February 2026 |
New thresholds for below 40 and above 75 year olds for PSA. |
revision 2026.016 |
|
Updated turnaround time for leukaemia immunophenotyping. |
revision 2026.015 | |
| 24 February 2026 |
Updated reference for lithium target range (range is unchanged). |
revision 2026.014 |
|
Change of address of referral lab for DPD deficiency, infliximab and anti-infliximab antibody, and adalimumab and anti-adalimumab antibody . |
revision 2026.013 | |
|
Update to Histopathology and Cytopathology turnaround times. |
revision 2026.012 | |
| 3 February 2026 |
Updated content for blood sample draw order. |
revision 2026.011 |
| 2 February 2026 |
Update to turnaround time information for BCR-ABL and T-cell gene rearrangement. |
revision 2026.010 |
|
Additional sample information added to Down, Edwards and Patau syndrome screening |
revision 2026.009 | |
| 28 January 2026 |
New listings for NPM1 gene transcript monitoring and FISH. |
revision 2026.008 |
| 20 January 2026 |
Listings for infliximab and anti-infliximab antibody and adalimumab and anti-adalimumab antibody updated to match referral lab's current reporting. |
revision 2026.007 |
| 19 January 2026 | Fabry screen - added information on genetic testing. | revision 2026.006 |
| 14 January 2026 | Note added to platelet function studies to identify as Not UKAS Accredited. | revision 2026.005 |
| New revision of blood culture fill volumes poster - see taking blood cultures | revision 2026.004 | |
| 6 January 2026 | New page for Virology monthly performance data | revision 2026.003 |
| 5 January 2026 | Serum creatinine 8h stability limit removed. | revision 2026.002 |
| Updates to CSF microbiology. | revision 2026.001 |
From the end of 2025:
| 24 December 2025 |
Updates to ethylene glycol and methanol - an in-house service is now available on weekdays. |
revision 2025.068 |
| 17 December 2025 |
Addition of test indications and key factors affecting test performance or interpretation to: group and screen, antibody investigation / quantitation (transfusion), direct antiglobulin test (DAT), Kleihauer test, cold agglutinins, crossmatch, fetal Rh D testing and ROTEM. |
revision 2025.067 |
| Paroxysmal nocturnal haemoglobinuria - TAT updated and test indications added. |
revision 2025.066 |
|
| 15 December 2025 | CRP listing updated - minimum requesting interval restrictions implemented from 15/12/2025 |
revision 2025.065 |
Note some links in old pages may be broken where content has subsequently been removed and pages may have had further updates since those listed below.